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Purpose: Migration of endovascular stent grafts has been related to the security of proximal device fixation to the aortic
neck. This study evaluated the importance of iliac fixation in preventing longitudinal in vivo device displacement of a
modular, externally supported stent graft.
Methods: Experimental ovine infrarenal aneurysms (n  8) were treated with a fully supported, modular, bifurcated stent
graft (AneuRx, Medtronic, Santa Rosa, Calif). Minimum iliac fixation length (1 cm) was used in four animals and iliac
extender modules were used to achieve maximum iliac fixation in four animals. Suture anastomosis of bifurcated polyester
grafts to the infrarenal aorta served as controls (n  8). Aortic grafts were displaced in vivo by applying downward
traction to a guidewire that was passed over the iliac flow divider and brought out both femoral arteries. The displacement
force needed to initiate stent-graft migration was recorded and compared with the force needed to disrupt the sutured
anastomosis.
Results: There was no difference in animal weight (88.8 2.5 kg vs 87.5 2.9 kg), aortic neck diameter (12.7 0.9 mm
vs 13.4  1.1 mm), aortic neck length (23.2  0.9 mm vs 21.8  2.4 mm), experimental aneurysm size (24.7  1.1 mm
vs 24.2 2.0 mm), or iliac artery diameter (9.0 1.5 mm vs 9.3 0.5 mm) among the groups. Iliac fixation length was
31.0 0.3 mm in the maximum iliac fixation group and 11 0.25mm in the minimum fixation group (P< .0001). Peak
displacement force to initiate migration was 30.2  5.5 N (range, 25 to 38) in animals with maximum iliac fixation
compared with 18.1  3.7 N (range, 13 to 21) in those with minimum fixation (P  .01). The force needed to disrupt
the control surgical anastomosis was 40.6  7.5 N (range, 31 to 50) (P < .01).
Conclusions:Maximizing iliac fixation length increases the longitudinal in vivo force needed to displace a fully supported
stent graft by 67%. This suggests that increasing iliac fixation length may reduce the long-term risk of migration in
patients undergoing endovascular aneurysm repair. ( J Vasc Surg 2005;41:664-71.)Endovascular aneurysm repair has gained acceptance in
the treatment of abdominal aortic aneurysms with favorable
results compared with open surgery .1-3 Large, prospective,
clinical trials have reported freedom from aneurysm-related
death in 97% of patients and freedom from surgical conver-
sion in 90% of patients after 4 years.4 However, the long-
term results of endovascular aneurysm repair may be com-
promised by late adverse events such as endograft
migration, aneurysm enlargement, stent fracture, and en-
doleaks.
Migration has been reported with all endovascular
devices, with an incidence of 2% at 1 year in each of
the clinical trials of United States Food and Drug Ad-
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664ministration (FDA)-approved devices.5-7 The cause of
migration is most often associated with abnormalities of
the proximal aortic neck and problems with fixation and
seal of the proximal end of the endograft to the aortic
neck.
Increasing neck angulation and neck diameter, 30%
proximal graft oversizing, short proximal aortic neck
length, and low initial device deployment in relation to the
renal arteries have all been shown to increase the risk of
migration.8-14 However, the importance of distal fixation
to the iliac arteries in relation to stent graft migration has
received little attention.
The purpose of this study was to determine whether
iliac fixation length is an important factor in resisting in vivo
device displacement of a bifurcated endograft with longi-
tudinal columnar support. An experimental model was used
to compare a modular, externally supported stent graft
(AneuRx, Medtronic, Santa Rosa, Calif) with standard
prosthetic aortic grafts that has a sutured anastomosis to the
aorta.
METHODS
An ovine model of surgically constructed abdominal
aortic aneurysms was used. The sheep were premedicated
with intravenous (IV) ketamine (10 mg/kg ) and Valium
(0.5mg/kg IV) (Roche Laboratories) or intramuscular
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IM) was given to decrease respiratory secretions and
prevent bradycardia. Upon induction of light anesthesia,
the subject animal was intubated. Isoflurane (1.0% to
5.0% to effect by inhalation) in oxygen was administered
to maintain a surgical plane of anesthesia. The heart rate,
rhythm, blood pressure, hemoglobin oxygen saturation,
and respiratory rate were monitored throughout the
procedure.
A midline laparotomy was performed after adequate
general endotracheal anesthesia was obtained and appropri-
ate monitoring catheters were placed. The proximal aorta
and common iliac arteries were dissected and controlled.
The animal was heparinized with 100 U/kg of heparin and
the activated clotting time was maintained 250 seconds
throughout the procedure.
The infrarenal aorta and iliac arteries were clamped and
the anterior wall of the aorta was opened, beginning 2.5 cm
below the lowermost renal artery. A large, polyester He-
mashield fabric patch (Boston Scientific, Natick, Mass) was
sutured to the anterior aortotomy, creating an aneurysmal
dilatation of infrarenal aorta that was twice the normal
diameter of the aorta (Fig 1).
The infrarenal neck of each experimental aneurysm was
20 mm long. The inferior junction of lowermost renal
artery was marked with surgical clips that served as the
reference marker for subsequent fluoroscopic determina-
tion of stent-graft movement and displacement. The mid-
line laparotomy was then closed with a running 2-0 Prolene
(Ethicon, Somerville, NJ) suture.
Bilateral groin incisions were made for exposure of the
common femoral arteries. Using the Seldinger technique,
the femoral arteries were accessed with bilateral 7F sheaths.
A marker pigtail catheter was placed at the level of the renal
arteries, and an angiogram was obtained to measure the
length from the renal arteries to the aortic trifurcation. The
aortic neck and common iliac artery diameters were mea-
sured manually with calipers applied to the outer wall of the
vessel after dissection. Computed tomography (CT) angio-
graphic measurements were not performed. Aortic anat-
omy is given in Table 1. These anatomic criteria were used
to choose the smallest diameter endograft (20  12 mm)
for both groups.
Two stiff 0.035 guidewires were positioned and a 20
 12 mm bifurcation stent-graft module (AneuRx) was
advanced to the level of the renal arteries and deployed
under fluoroscopic guidance. The bifurcation module
was rotated and positioned in a cross-limbed fashion.
This was done to shorten the effective length of the stent
graft, because the shortest graft available was 13.5 cm
and the distance from the renal arteries to the trifurca-
tion was 11 cm. By crossing the iliac limbs, the effective
length of the device was decreased by 1.5 cm, which
resulted in an iliac fixation length of about 1 cm. This
configuration was maintained in both groups of animals
so as not to be a confounding variable.
After the bifurcation module was deployed, the gate
was cannulated and the contralateral iliac limb was de-ployed with a similar 1-cm iliac fixation length. Standard
bifurcation device deployment with short iliac fixation
(1 cm) was used in four animals. In four animals, iliac
extender modules were deployed bilaterally to cover the
entire length of the common iliac arteries. This resulted in
a 3-cm iliac fixation length bilaterally (maximum iliac fixa-
tion group).
After stent graft placement, a 0.035 glidewire was
snared above the flow divider and brought out through
the contralateral femoral artery (Fig 2). A catheter was
advanced over the wire to protect the top edge of the
bifurcation module flow divider. Both ends of the wire
were connected to a Chatillon TurboGauge at the foot of
the animal. Under fluoroscopic control, continuous lon-
gitudinal downward traction was applied to each aortic
endograft by pulling on both ends of the guidewire (Fig
3). Movement of the stent graft in relation to the mark-
ers on the lowermost renal artery was recorded by cine
fluoroscopy. The peak force at the time of initial stent
graft displacement was recorded by the TurboGauge and
was measured in newtons. Migration was defined as an
increase in distance from the lowermost renal artery to
the top of the stent graft.
After the pull-down force measurements were com-
pleted, the abdominal cavity was reopened. The aorta and
iliac arteries were cross-clamped, the experimental aneu-
rysm was opened, and the stent graft was removed. The
suprarenal aorta was transected and a bifurcated 14 7mm
knitted Dacron (DuPont) surgical graft was sutured end-
to-end to normal aorta that had not been previously ma-
nipulated The anastomosis was performed with a running
4-0 Prolene suture.
After the anastomosis was completed, a glidewire was
passed over the flow divider of the surgical graft and
brought out both limbs of the graft. A catheter was
passed over the glidewire to protect the flow divider of
the Dacron (DuPont) graft. Both ends of the glidewire
were connected to the Chatillon TurboGauge in the
same manner as had been previously used to apply down-
ward traction force to the stent graft. Clamps were
applied to the iliac limbs and the proximal aortic clamp
was removed. Downward traction force was applied to
the aortic graft, with video image observation and re-
cording of the aortic anastomosis.
The peak force recorded on the Chatillon Turbogauge
at the time the anastomosis began to tear was measured and
recorded in newtons. The aorta was then immediately
cross-clamped and the sheep was euthanized. All device
implant and explant procedures were performed in accor-
dance with the Principles of Laboratory Animal Care and
the Animal Welfare Act (1970 and amendments) and ap-
proved by the animal care committee.
Results are reported as the mean standard deviation.
Differences between two groups were performed using the
Student t test. Differences among the three groups were
analyzed using analysis of variance. A P  .05 was consid-
ered statistically significant.
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There was no difference in animal size (88.8 2.5 kg
vs 87.5  2.9 kg), aortic neck diameter (12.7  0.9 mm
vs 13.4  1.1 mm), aortic neck length (23.2  0.9 mm
vs 21.8  2.4 mm), aneurysm size (24.7  1.1 mm vs
24.2  2.0 mm), or iliac artery diameter (9.0  1.5 mm
vs 9.3  0.5 mm) between the groups with minimum and
maximum iliac fixation. Complete aorta morphology is given
Fig 1. An experimental aortic aneurysm was created by
the aorta, leaving an infrarenal aortic neck length of 2 cm
graft was deployed under fluoroscopic control.







(3 cm) (n  4)
Aortic neck length (mm) 23.2  0.9 21.8  2.4
Aortic neck diameter (mm) 12.7  0.9 13.4  1.1
Aneurysm diameter (mm) 24.7  1.1 24.2  2.0
Distal aorta diameter (mm) 12.0  0.8 12.1  0.7
Right common iliac
diameter (mm)
9.0  1.5 9.3  0.5
Left common iliac
diameter (mm)
9.0  1.6 9.3  0.9
Renal to bifurcation length
(mm)
110  1.3 110  1.5
*Values shown are mean  SD; P  NSin Table 1.The smallest diameter aortic endograft was chosen for
all eight sheep experiments. The device was a 20 x 12 mm
AneuRx aortic graft. This resulted in 50% oversizing of the
graft in the proximal neck for the minimum iliac fixation
group, a 57% oversizing in the maximum iliac fixation
group (PNS), and a 30% oversizing of the iliac vessels in
both groups. The length of the bifurcation module was
13.5 cm in all animals.
In animals with minimum iliac fixation, no extender
cuffs were placed. In animals with maximal iliac fixation,
one 5.5-cm extender cuff was placed on each side with a
2.5-cm overlap between the iliac limb and the extender
cuff. Iliac fixation length was 31.0  0.3 mm in maximum
fixation animals and 11  0.25 mm in minimum fixation
animals (P  .0001).
The peak force to initiate migration was 30.2  5.5 N
(range, 25 to 38) in animals with maximum iliac fixation
compared with 18.1  3.7 N (range, 13 to 21) in those
with minimum iliac fixation (P  .01) (Table II). The peak
force to disrupt the surgical anastomosis was 40.6 7.5 N
(range, 31 to 50), which was greater than both the mini-
mum and maximum fixation groups (P  .01).
DISCUSSION
Long-term success of endovascular aneurysm repair
g a large Dacron (DuPont) patch to the anterior wall of
r closure of the abdomen, a bifurcated endoluminal stentsewin
. Aftedepends on secure intra-aortic device fixation. Failure of
is re
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endoleaks, and aneurysm rupture. Migration of en-
dografts is a recognized complication of all devices and
often occurs 12 months. Factors that have been impli-
cated in device migration include short aortic neck, large
neck diameter, neck angulation, and excessive device
oversizing.8-15
Most studies of migration have focused on proximal
fixation to the infrarenal aortic neck. Efforts to prevent
migration have been focused on improving proximal fixa-
tion mechanisms and identifying and avoiding treatment of
Fig 2. A glidewire is passed over the flow divider and bro
to both ends of the glidewire and the displacement force
Fig 3. Stent graft peak pull-out force fixture.patients with unfavorable neck anatomy. In vitro modelshave been used to evaluate and compare proximal fixation
mechanisms of various stent-graft designs with measure-
ment of resistance to downward displacement compared
with sutured anastomoses.16-19
Resch et al19 compared the proximal fixation of the
Ancure (Guidant), Talent (Medtronic), Vanguard (Bos-
ton Scientific), Zenith (Cook), and the Palmaz (Cordis)
stents with a hand-sewn surgical anastomosis. In this
study, the proximal graft was placed in the aorta and
attached by a hook to a dynamometer that was used to
measure the displacement force. The distal end of the
out both femoral arteries. Downward traction is applied
corded.ughtdevice was not deployed and was not fixed to iliac
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dograft migration was 4.5 N for Talent, 9.0 N for
Vanguard, 12.5 N for Ancure, 24 N for Zenith, and 25 N
for Palmaz. The force needed to disrupt the sutured
aortic anastomosis was 150 N.19
Static experimental studies provide useful information
on proximal fixation mechanisms, but they may not reflect
in vivo behavior of devices because they do not take into
account the dynamic in vivo environment. Furthermore,
they do not take into account the intravascular position of
the device, the iliac fixation component, or the longitudinal
columnar characteristics of the device.
Morris et al20 used a mathematical model to predict
the in vivo pulsatile drag forces acting on a bifurcated
stent graft used in the endovascular treatment of abdom-
inal aortic aneurysms and defined the forces acting on the
graft. These forces include the velocity of flow at the
proximal and distal ends of the graft as well as the
pressure and the velocity of flow through the body and
limbs of the graft.
The reaction forces needed to counteract these drag
forces included the proximal neck fixation length, the col-
umn strength of the main body of the graft, the column
strength of the iliac limbs, and the fixation of the iliac limbs
to the common iliac arteries. For a rigid graft with a
proximal diameter of 24 mm and an iliac diameter of 12
mm, they calculated the variation in the drag force along
the y-axis between 2.7 and 4.1 N during one cardiac
cycle.20 The authors determined that these were the mini-
mum forces that stent grafts needed to withstand to provide
adequate long-term fixation. Previous studies have only
looked at the reactionary forces of proximal neck fixation
length and various proximal neck stent configurations to
prevent migration and have failed to consider iliac fixation
length.
The importance of iliac fixation in improving the reac-
tion forces to downward displacement has yet to be fully
evaluated. However, from the results of this study, it ap-
pears there is a significant increase in the force needed to
displace an aortic endograft that has longitudinal columnar
strength when iliac fixation length is increased. We found
that the force needed to displace the endograft was in-
creased by 12 N (67%) when iliac fixation length was
increased by 2 cm on each side.
Thus, it appears that the reactionary forces of iliac
fixation length and, more important, the column
strength of the iliac limbs are significant factors in resist-
Table II. Aortic and iliac fixation length and force necessa
Aortic fixation length (mm)
Minimum fixation (n  4) 21.8  2.4
Maximum Fixation (n  4) 23.2  1.0
Surgical anastomosis (n  8)
*P  0.01
†P  0.01ing longitudinal loads that can cause stent-graft migra-tion. This suggests that using longer endografts that
extend to the hypogastric arteries or placing iliac ex-
tender modules to increase iliac fixation length in pa-
tients may reduce the likelihood of stent-graft migration.
This has now become the standard in our clinical practice
and is supported by retrospective review of our endograft
experience.21 Further prospective studies will be needed
to confirm these observations.
The pulsatile forces of aortic blood flow exert continu-
ous downward displacement force on aortic devices, with
cumulative effects over time. Thus, it is not surprising that
migration has occurred and been reported with all current
endovascular devices and configurations, including those
with modular design, unibody design, infrarenal fixation,
suprarenal fixation, hook and barb fixation, longitudinal
columnar support, and flexible designs. The reported inci-
dence of endograft migration varies widely and comparison
is complicated by different definitions of migration and
differing follow-up periods. Migration has been noted with
all FDA-approved devices with similar migration rates of 2%
at 1 year.4-7 Most studies have attributed this risk of migra-
tion to issues of the proximal neck.8-14, 22-23
Although in situ placement and maximum iliac fixa-
tion length of externally supported endografts signifi-
cantly increases resistance to longitudinal device dis-
placement, it still does not achieve the fixation security of
hand-sewn surgical anastomoses as demonstrated in this
and other studies.16-19 The AneuRx stent graft chosen in
this study is held in place by radial force and columnar
strength. Devices with other fixation mechanisms, in-
cluding suprarenal stents, hooks and barbs, and differing
columnar strength characteristics may behave differently
and deserve to be studied. Such studies may help eluci-
date the relative importance of proximal and distal fixa-
tion and the role of columnar support in preventing
device migration.
It should be recognized, however, that short-term ex-
perimental animal studies provide little insight to long-
term device behavior. Late endograft failures have occurred
in numerous devices after aortic implantation. Fatigue fail-
ures include delayed hook and barb fractures, metallic stent
fractures, suture disruptions, and late failure of aortic neck
attachments,23-25 and these factors may have a role in late
device migration.
The present study has several weaknesses. The first is
that the endograft in the infrarenal aorta and iliac arteries
was significantly oversized. This limitation was because of
r displacement
Iliac fixation length (mm) Displacement force in newtons
11  0.25 18.1  3.7 (13-21)
31.0  0.3 30.2  5.5 (25-38)*
40.6  7.5 (31-50)†ry fothe size of the ovine aorta-iliac system and the size of
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results is unknown. Typically, oversizing of 10% to 20% is
used for endograft placement. In this study, the proximal
neck was oversized between 50% and 57%, with the smallest
available endograft being used in all animals.
In the Zenith Multicenter Trial, Sternbergh et al14
have shown that device oversizing of 30% is associated
with a higher risk of migration (14% migration rate)
compared with those with30% oversizing (0.9% migra-
tion rate). Furthermore, it has been shown that eccentric
compression of the proximal graft of the AneuRx graft as
a result of aggressive oversizing was associated with an
increased risk of stent graft migration.15 This suggests
that the force needed to displace the endograft in this
experiment might have been higher if the device could
have been sized in accord with the recommended 10% to
20% oversizing. Nonetheless, there was no difference in
the degree of oversizing between the two groups so the
effect of incorrect oversizing should be the same in both
groups.
The aortic neck length used in this experiment was 20
mm. This is similar to neck lengths commonly encountered
in patients undergoing endovascular aneurysm repair. The
mean aortic neck lengths of patients treated in prospective
clinical trials of various endografts was 20 mm.4-7 How-
ever, migration most likely will occur in patients with aortic
neck lengths15mm.Whether the in vivo forces necessary
to displace the endograft downward would remain the
same with maximum iliac fixation and a shorter proximal
neck length would require further study.
Because this was a short-term study in which displace-
ment forces were measured directly after implantation of
the endograft, no conclusions can be drawn on the resis-
tance to displacement of devices that have been in place for
longer periods of time, and the study does not account for
any possibility of biologic fixation of the graft that might
occur. Further long-term studies should be performed to
determine if length of implant results in a significant differ-
ence in displacement forces. Future studies should evaluate
the long-term effect of iliac fixation and its role inmigration
in large clinical studies such as the multicenter AneuRx
clinical trial.
In conclusion, increasing the iliac fixation length of a
fully supported endovascular graft significantly increases
the resistance to in vivo longitudinal stent-graft displace-
ment in a short-term experimental model. This suggests
that increasing iliac fixation length in patients may re-
duce the likelihood of stent-graft migration in patients.
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Dr Tim Chuter (San Francisco, Calif). Thank you, Doctor
Arko, for sending me a copy of the paper to review. It is not easy
to do meaningful animal studies of this type, and this study of
column strength certainly deserves an “A” for effort. I agree
with your conclusion that the addition of two extender limbs
increased the pullout force at the proximal end of the stent graft.
The question is, why and what does this mean in terms of clinical
application?
The first thing to note is that the additional iliac stent grafts
not only extended two centimeters down into the iliac arteries, but
also three and a half centimeters up into the existing graft limbs
within the distal aorta. In this ovine model, the distal aorta mea-
sured only thirteen millimeters in diameter and was barely big
enough to accommodate one twelve-millimeter graft limb. With
the addition of the iliac extensions it contained four. I suggest that
the observed effects on pullout force showed the effects of addi-
tional bulk and stiffness. The top end of the stent-graft just had
nowhere to go.
Can we expect to see the same effect in clinical use where the
range of angulation is far larger, the aneurysm far wider, and one
hundred percent oversizing is very unlikely? I think not. Angula-
tion of the aorta is important because it increases the laterally
directed component of any hemodynamic displacement forces and
increases the likelihood of buckling.
The term column strength applies only to columns that are stiff
and straight, not to stent grafts, which are flexible and bent. I agree
withDoctor Arko that one should aim to implant a bifurcated stent
graft of this type as close to the common iliac bifurcation as
possible. This has been common practice among experienced users
for a decade. But the best way to achieve adequate iliac overlap is
not the routine addition of iliac extensions. Nor do I believe that
iliac extensions increase the stability of the proximal end of the
stent graft. Very long extensions might add a little stiffness to the
limbs but not enough to have a significant effect on the incidence
of proximal stent-graft migration, given the size and angulation of
the typical infrarenal aortic aneurysm.
I have only one question for Doctor Arko. Where is the
bifurcation of the common iliac artery in a sheep? Because as you
know, the ovine internal iliac arteries are branches of the middle
sacral artery. Thank you.
Dr Arko. There is a large branch that comes off the common
iliac artery approximately three centimeters from the aortic bifur-
cation in a sheep. The graft was extended to that branch.
Dr James Watson (Seattle, Wash). I would like to congratu-
late Doctor Arko for what I consider to be a very elegant study. I
don’t understand how pulling on the distal end of the graft to test
the proximal anastomosis can be affected by distal fixation. It seems
like you are pulling on the distal fixation the same no matter how
long that fixation is, so how can altering the length of distal fixation
alter the strength at the proximal anastomosis?
Dr Arkro. Imagine the Eiffel Tower, it is very similar to that.
It adds more column strength to the graft and, as Tim said, makes
it stiffer. If you look at engineeringmodels and computational fluid
dynamics of endografts one can determine the amount of drag
forces on an endograft. Those drag forces are based on the blood
pressure and volume of flow at the proximal anastomosis, the distal
anastomosis, and both distal fixation sites. However, there are
multiple reactionary forces to counteract those drag forces and
those include the proximal fixation length, the amount of oversiz-
ing, and the distal fixation of both the right and the left iliac limbDr William Quinones-Baldrich (Los Angeles, Calif). I
want to congratulate you on the effort to create an animal model
where we can study some of these things. It has been surprising
to me that after ten years performing endovascular repair of
abdominal aortic aneurysm, there are very few animal studies to
evaluate the various designs. One of the main issues is whether
it is the extension of the fixation site or the addition of colum-
nar strength that is beneficial. Could you tell us if when the graft
moved proximally, did it also move distally or did it just buckle?
Dr Arko. That is a very good question. It buckled at the
flow divider. We explanted these stent grafts and the iliac limbs
were stiff throughout and the proximal portion of the graft was
buckled.
Dr Ronald Dalman (Stanford, Calif). I would just like to
make a comment, Frank. You know, I understand the point of a
standardized pseudoaneurysm model, with measurable and repro-
ducible diameter of the aneurysm, but what we are really talking
about here is a normal aorta with a patch on it and not really an
aneurysm. It is a pseudoaneurysm, so I think we have to move on
to some more biologically relevant models, because this does
provide a platform for comparing newton force but what causes the
graft to migrate in traditional terms of an atherosclerotic aneurysm
may be different than what causes it to move in a pseudoaneurysm
with a patch on a normal aorta.
Dr Joseph Mills (Tucson, Ariz). I applaud you for trying to
look at animal models because, as Doctor Quinones said, we don’t
have enough data for that, but what I am concerned about is does
the animal model really apply to humans? Migration to me implies
movement of the graft over time due to multiple issues, which
could have to do with the proximal fixation length, distal fixation
length, and also how much columnar support you have for the
graft, and you are not really measuring migration. You are measur-
ing the nonpulsatile force it takes to distract the proximal seal,
which may not have anything to do with migration.
I am also concerned that with your model you are putting stiffer
extensions inside your limbs and basically you are increasing your
aortic seal because your aneurysms aren’t that big. They are less than
double the diameter of the native artery, so by putting these stiff
supports in you are also increasing your fixation length in the distal
aorta, not just the iliacs. I amnot sure that you aremeasuringwhat you
want to measure. Migration to me would mean you would measure
movement over time so you would have to have a chronic model.
Another way to get at it, which I think might be easier, is we all have
serialMMS three-DCTmeasurements in all our patients. It would be
easy to look at proximal fixation neck length, neck angulation, iliac
fixation, and do a uni and multivariate analysis and see what factors
actually influence migration.
Dr Arko. I agree, and we have done that and that abstract has
been submitted to the Southern Vascular.
Dr William Krupski (San Francisco, Calif). Frank, this isn’t
related to your model but have you noted in your clinical experi-
ence any proximal migration of grafts through the exoskeleton,
kind of pushing it up if your graft is accordioned in the aorta? Have
you seen that coverage of the renals after it has been put in?
Dr Arko. Migrating cranially?
Dr Krupski. Proximally, up toward the renals.
Dr Arko. I have not seen that. I have heard about that in
one case. I have also operated on a patient who had an endograft
placed at an outside institution where the renals were suppos-
edly visualized postprocedure and then a week later he became
very hypertensive and one of his renals was completely covered
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He was brought to us and I put a guide wire over the
flow divider. I brought both ends of the guide wire out thejust could not move the graft. It had been in there about four
weeks, so I actually explanted that stent graft the following week
and it was fairly well incorporated in both the iliacs and thefemoral arteries and attempted to pull the graft down, but we proximal neck.
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